These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 17389013

  • 21. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis.
    Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P.
    Arthritis Rheum; 1999 Jun; 42(6):1101-8. PubMed ID: 10366102
    [Abstract] [Full Text] [Related]

  • 22. Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype.
    Dieudé P, Bouaziz M, Guedj M, Riemekasten G, Airò P, Müller M, Cusi D, Matucci-Cerinic M, Melchers I, Koenig W, Salvi E, Wichmann HE, Cuomo G, Hachulla E, Diot E, Hunzelmann N, Caramaschi P, Mouthon L, Riccieri V, Distler J, Tarner I, Avouac J, Meyer O, Kahan A, Chiocchia G, Boileau C, Allanore Y.
    Arthritis Rheum; 2011 Dec; 63(12):3979-87. PubMed ID: 21898345
    [Abstract] [Full Text] [Related]

  • 23. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
    Wei YS, Kuang XH, Zhu YH, Liang WB, Yang ZH, Tai SH, Zhao Y, Zhang L.
    Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population.
    Vishnoi M, Pandey SN, Choudhuri G, Mittal B.
    Cancer Genet Cytogenet; 2008 Oct 15; 186(2):63-8. PubMed ID: 18940468
    [Abstract] [Full Text] [Related]

  • 26. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
    Ito I, Kawaguchi Y, Kawasaki A, Hasegawa M, Ohashi J, Hikami K, Kawamoto M, Fujimoto M, Takehara K, Sato S, Hara M, Tsuchiya N.
    Arthritis Rheum; 2009 Jun 15; 60(6):1845-50. PubMed ID: 19479858
    [Abstract] [Full Text] [Related]

  • 27. Single-nucleotide polymorphisms in CCL2 gene are not associated with susceptibility to systemic sclerosis.
    Carulli MT, Spagnolo P, Fonseca C, Welsh KI, duBois RM, Black CM, Denton CP.
    J Rheumatol; 2008 May 15; 35(5):839-44. PubMed ID: 18381789
    [Abstract] [Full Text] [Related]

  • 28. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
    Chourasia D, Achyut BR, Tripathi S, Mittal B, Mittal RD, Ghoshal UC.
    Am J Gastroenterol; 2009 Nov 15; 104(11):2704-13. PubMed ID: 19603010
    [Abstract] [Full Text] [Related]

  • 29. Inflammatory cytokine gene variants in coronary artery disease patients in Greece.
    Manginas A, Tsiavou A, Chaidaroglou A, Giamouzis G, Degiannis D, Panagiotakos D, Cokkinos DV.
    Coron Artery Dis; 2008 Dec 15; 19(8):575-82. PubMed ID: 19005292
    [Abstract] [Full Text] [Related]

  • 30. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
    Ahirwar D, Mandhani A, Mittal RD.
    Arch Med Res; 2009 Feb 15; 40(2):97-102. PubMed ID: 19237018
    [Abstract] [Full Text] [Related]

  • 31. Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis.
    Mattuzzi S, Barbi S, Carletto A, Ravagnani V, Moore PS, Bambara LM, Scarpa A.
    J Rheumatol; 2007 May 15; 34(5):997-1004. PubMed ID: 17444587
    [Abstract] [Full Text] [Related]

  • 32. The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype.
    Rueda B, Broen J, Torres O, Simeon C, Ortego-Centeno N, Schrijvenaars MM, Vonk MC, Fonollosa V, van den Hoogen FH, Coenen MJ, Sanchez-Román J, Aguirre-Zamorano MA, García-Portales R, Pros A, Camps MT, Gonzalez-Gay MA, Martin J, Radstake TR.
    Ann Rheum Dis; 2009 Feb 15; 68(2):253-6. PubMed ID: 18713787
    [Abstract] [Full Text] [Related]

  • 33. Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects.
    Sugimoto M, Furuta T, Shirai N, Nakamura A, Kajimura M, Sugimura H, Hishida A.
    J Gastroenterol Hepatol; 2007 Sep 15; 22(9):1443-9. PubMed ID: 17716348
    [Abstract] [Full Text] [Related]

  • 34. The polymorphisms of interleukin-10 gene influence the prognosis of patients with advanced melanoma.
    Vuoristo MS.
    Cancer Genet Cytogenet; 2007 Jul 01; 176(1):54-7. PubMed ID: 17574964
    [Abstract] [Full Text] [Related]

  • 35. Association of IL-4 and IL-10 gene promoter polymorphisms with common variable immunodeficiency.
    Rezaei N, Aghamohammadi A, Mahmoudi M, Shakiba Y, Kardar GA, Mahmoudi M, Moradi B, Amirzargar AA.
    Immunobiology; 2010 Jul 01; 215(1):81-7. PubMed ID: 19249119
    [Abstract] [Full Text] [Related]

  • 36. Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity.
    Szücs G, Szekanecz Z, Zilahi E, Kapitány A, Baráth S, Szamosi S, Végvári A, Szabó Z, Szántó S, Czirják L, György Kiss C.
    Rheumatology (Oxford); 2007 Jun 01; 46(6):989-93. PubMed ID: 17384178
    [Abstract] [Full Text] [Related]

  • 37. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
    Matsushita T, Hasegawa M, Hamaguchi Y, Takehara K, Sato S.
    J Rheumatol; 2006 Feb 01; 33(2):275-84. PubMed ID: 16465658
    [Abstract] [Full Text] [Related]

  • 38. IL-10 promoter polymorphisms influence disease severity and course in psoriasis.
    Kingo K, Kõks S, Silm H, Vasar E.
    Genes Immun; 2003 Sep 01; 4(6):455-7. PubMed ID: 12944983
    [Abstract] [Full Text] [Related]

  • 39. Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study.
    Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B.
    Hum Immunol; 2008 Mar 01; 69(3):179-86. PubMed ID: 18396210
    [Abstract] [Full Text] [Related]

  • 40. Interleukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands.
    Rosado S, Rua-Figueroa I, Vargas JA, Garcia-Laorden MI, Losada-Fernandez I, Martin-Donaire T, Perez-Chacon G, Rodriguez-Gallego C, Naranjo-Hernandez A, Ojeda-Bruno S, Citores MJ, Perez-Aciego P.
    Int J Immunogenet; 2008 Jun 01; 35(3):235-42. PubMed ID: 18397303
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.